Tilray Announces Second Facility To Meet Rapidly Growing Global Demand For Medical Cannabis

Total output to increase to 51 metric tonnes annually by end of 2018

CANADA: Tilray Canada Ltd., a global leader in medical cannabis research and production, has announced that it will invest, through an affiliated entity, up to $30 million in a second cultivation and processing facility located in Enniskillen, Ontario. The two facilities will generate a combined production capacity of up to 51 metric tonnes per year, which will Read the full article…

NY Department Of Health Proposes Regulations That Would Expand Medical Marijuana Program

New York’s Proposed Expansion Of Medical Marijuana Regulations

NEW YORK: The Department of Health just announced the issuance of new proposed regulations that would make changes to the state’s medical marijuana program to improve access. Among other things, they would reduce some of the onerous security requirements for registered organizations, shorten the length of the medical marijuana course certifying practitioners must take from Read the full article…

Intec Pharma Reports Clinical Results From Phase I Trial of Accordion Pill For Cannabinoid Therapies

Intec Pharma Reports Clinical Results From Phase I Trial of Accordion Pill for Cannabinoid Therapies

ISRAEL: Intec Pharma, a clinical stage biopharmaceutical company focused on developing drugs based on its proprietary Accordion Pill platform technology, announced the results from a Phase I clinical trial of AP-CBD/THC, its Accordion Pill platform with cannabidiol (CBD) and tetrahydrocannabinol (THC), the two primary cannabinoids contained in Cannabis sativa. “We’re excited about these encouraging results from our Read the full article…

Why Cannabis Is A Medication That’s Worth Legalizing

Why Cannabis Infographic

Chronic pain is a large problem.  Not only does 1/3 America suffer from it, but because the pain is both subjective and personal, it has been very difficult to treat. In fact, until the 1990s, it went largely under treated until opioid prescriptions began to rapidly increase. Today, we have an epidemic. But, while marijuana Read the full article…

Case Reports: Cannabis Smoking Associated With Spontaneous Remission Of Restless Legs Syndrome

Muscles - Legs Front - Fitness for You

FRANCE: Cannabis inhalation alleviates symptoms in patients with restless legs syndrome (RLS), according to a series of case reportspublished in the journal Sleep Medicine. Up to ten percent of the US population is estimated to suffer from RLS. French researchers reported on the experience of six patients with treatment-resistant RLS following cannabis inhalation. All patients reported “total relief of RLS Read the full article…

Study: CBD Administration Reduces Blood Pressure

Gov. Butch Otter has vetoed the bill that would have allowed parents of Idaho children with an intractable form of epilepsy to treat their kids with cannabidiol.

UNITED KINGDOM: Oral CBD administration is associated with reduced blood pressure in healthy volunteers, according to clinical trial data published online in the Journal of Clinical Investigation. Investigators from the University of Nottingham assessed the effects of a single oral dose of 600 mg of CBD extract versus placebo in nine male subjects. Cannabidiol administration reduced resting systolic blood Read the full article…

PA Marijuana Dispensary Agent Training Class In Pittsburgh Sunday, June 25th

medical  cannabis job training in PA

PENNSYLVANIA: HempStaff, a medical marijuana staffing and training agency, is hosting a Medical Marijuana Dispensary Agent Training Class in Pittsburgh, Pennsylvania on Sunday, June 25, 2017. The class will be held at the Embassy Suites Pittsburgh, located at 550 Cherrington Parkway, Coraopolis, Pennsylvania. There are 2 sessions to choose from: 8:00 a.m.-12:00 p.m. or 1:30 p.m.-5:30 p.m. The cost is $249 with prior online registration or $300 (cash-only) at the door, Read the full article…

Tilray Announces Support For Clinical Trial Examining Cannabis And Chronic Lung Disease

Tilray clinical trials progress

CANADA: Tilray, a global leader in medical cannabis research and production, today announced a partnership with the Research Institute of the McGill University Health Centre (RI-MUHC) in Montreal, one of the world’s premier public academic and research institutions, to study the effects of vaporized cannabis on symptoms associated with chronic obstructive pulmonary disease (COPD). The Phase II trial will Read the full article…

Review Identifies 140 Controlled Clinical Trials Related to Cannabis

mmj

GERMANY: Scientists have conducted over 140 controlled clinical trials since 1975 assessing the safety and efficacy of either whole-plant cannabis or specific cannabinoids, according to a literature review published in the journal Critical Reviews in Plant Sciences. A pair of German researchers identified 140 clinical trials involving an estimated 8,000 participants. Of these, the largest body of literature focuses Read the full article…

Study: Maternal Cannabis Use Not Associated With Adverse Neurodevelopment

cannabis and maternal health

MARYLAND: Cannabis exposure in utero is not associated with any significant, long-lasting adverse outcomes in offspring, according to a scientific review published online ahead of print in the journal Preventive Medicine. A pair of researchers from the University of Maryland, Department of Obstetrics, Gynecology and Reproductive Sciences and the Virginia Commonwealth University, Department of Obstetrics and Gynecology and Psychiatry reviewed four Read the full article…